Nav: Home

To slow malaria, cure mosquitoes with drug-treated bed nets

March 11, 2019

For decades, one of the strongest weapons against malaria has been a one-two punch: low-tech mosquito bed nets to physically block biting, treated with deadly insecticides to kill the mosquitoes.

With widespread use of this combination, malaria deaths have dropped significantly -- though nearly 445,000 people died from the disease in 2016 alone. But now the threat is again worsening, as the ever-adaptable pest has become resistant to insecticides.

Lauren Childs, an assistant professor of mathematics in the Virginia Tech College of Science, has joined with researchers from Harvard University's T.H. Chan School of Public Health, to develop a solution that could prevent or even reduce additional malaria deaths.

Childs is second author on a paper published recently in Nature. Researchers found that they could use the same drug -- atovaquone -- used to treat the malaria parasite when a person gets sick, coat mosquito bed nets with it, and let mosquitoes ingest the anti-malarial drug. The medication "cures" the mosquito, so it can't spread the disease.

How did they get the medicine into the mosquitoes? The researchers covered the bed nets with it. Childs' contribution to the research involved developing computer models that explored how adding atovaquone to the bed nets and its ability to cure individual mosquitoes affected malaria prevalence in the human population as a whole. Childs' modeling factored in various external conditions, such as the current malaria prevalence, bed net coverage, and level of insecticide resistance.

They found that mosquitoes that sat on the surfaces for six minutes -- a typical resting time on bed nets -- would absorb the medicine needed to kill the malaria parasite in them. The method could be more effective and less harmful to the people and environment in malaria hotspots. It has several advantages over the current techniques, Childs said.

"The mosquito should not develop resistance to the compounds because we're just killing the parasite that's inside it," she said. "And atovaquone is already a licensed drug, so we know it's safe for humans."

A resurgence of malaria due to insecticide resistance among Anopheles mosquitoes is a major threat. Though the U.S. Centers for Disease Control reported that deaths dropped by 25 percent from 2010 to 2016, nearly 450,000 people across the globe died of malaria in 2016. Many of the deaths were children in sub-Saharan Africa.

Developing, getting approval for, and distributing new insecticides to which mosquitoes have not built a resistance could take too long, as malaria illnesses and deaths spread. Childs credited her colleagues at Harvard's Chan School and the transdisciplinary team that melded her mathematical modeling skills with expertise in epidemiology, biology, public health, and other fields to offer a potential solution to a major global problem.

And it's a solution that could possibly be implemented in time to make a difference, she said.

"The population in sub-Saharan Africa is accustomed to bed nets and already uses them," Childs said. "There are a lot of reasons this could move quickly to action."
-end-


Virginia Tech

Related Malaria Articles:

Could there be a 'social vaccine' for malaria?
Malaria is a global killer and a world health concern.
Transgenic plants against malaria
Scientists have discovered a gene that allows to double the production of artemisinin in the Artemisia annua plant.
Fighting malaria through metabolism
EPFL scientists have fully modeled the metabolism of the deadliest malaria parasite.
Should we commit to eradicate malaria worldwide?
Should we commit to eradicate malaria worldwide, asks a debate article published by The BMJ today?
Investigational malaria vaccine shows considerable protection in adults in malaria season
An investigational malaria vaccine given intravenously was well-tolerated and protected a significant proportion of healthy adults against infection with Plasmodium falciparum malaria -- the deadliest form of the disease -- for the duration of the malaria season, according to new findings published in the Feb.
Why malaria mosquitoes like people with malaria
Malaria mosquitoes prefer to feed -- and feed more -- on blood from people infected with malaria.
Malaria superbugs threaten global malaria control
A lineage of multidrug resistant P. falciparum malaria superbugs has widely spread and is now established in parts of Thailand, Laos and Cambodia, causing high treatment failure rates for the main falciparum malaria medicines, artemisinin combination therapies (ACTs), according to a study published today in The Lancet Infectious Diseases.
Considering cattle could help eliminate malaria in India
The goal of eliminating malaria in countries like India could be more achievable if mosquito-control efforts take into account the relationship between mosquitoes and cattle, according to an international team of researchers.
Seasonal malaria chemoprevention in Senegalese children lowers overall malaria burden
Giving preventive antimalarial drugs to children up to age 10 during active malaria season reduced the cases of malaria in that age group and lowered the malaria incidence in adults, according to a randomized trial carried out in Senegal and published in PLOS Medicine by researchers from the Université Cheikh Anta Diop, Senegal, the London School of Hygiene & Tropical Medicine, UK, and other collaborators.
How malaria fools our immune system
OIST researchers reconstruct the 3-D structure of a malaria protein in combination with human antibodies.

Related Malaria Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...